Ocular Therapeutix (OCUL) Invested Capital (2021 - 2023)
Ocular Therapeutix (OCUL) posted quarterly Invested Capital of $82.5 million for Q4 2023, up 119.9% year-over-year from $37.5 million in Q4 2022, and up 229.9% on a QoQ basis from $25.0 million in Q1 2023.
Ocular Therapeutix (OCUL) Invested Capital (2021 - 2023) Analysis & Trends
Ocular Therapeutix has reported Invested Capital for 3 years, with the latest figure at $82.5 million in Q4 2023.
- Invested Capital for Q4 2023 came in at $82.5 million, up 119.9% year-over-year; the trailing twelve-month figure through Sep 2024 was $82.5 million (up 31.95% YoY), and the FY2023 annual result was $82.5 million, up 119.9% from the prior year.
- Invested Capital grew to $82.5 million in Q4 2023, from $25.0 million in the prior quarter.
- Over five years, Invested Capital peaked at $82.5 million in Q4 2023 and troughed at $25.0 million in Q2 2021.
- A 3-year average of $38.0 million and a median of $29.0 million in 2021 frame the typical range for Invested Capital.
- The widest annual swing landed in 2022, when Invested Capital climbed 13.96%; it then jumped 119.9% in 2023.
- A 3-year view of Invested Capital shows it stood at $32.9 million in 2021, then increased by 13.96% to $37.5 million in 2022, then jumped by 119.9% to $82.5 million in 2023.
- Per Business Quant data, the three most recent Invested Capital figures were $82.5 million in Q4 2023, $25.0 million in Q1 2023, and $37.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 20.02 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Jun 30, 2021 | 25.00 Mn |